Lizo’s weightloss journey has been a transformation, what she referred to as “weight release journey” in 2023.Get breaking ...
So, how does Victoza compare to other GLP-1 medications, including semaglutide or tirzepatide? Here’s what you need to know ...
Roche said on Friday that patients lost 22.7% of their body weight in a mid-stage trial of its dual-acting experimental ...
Eli Lilly just released impressive study results for retatrutide, an investigational weight loss drug that targets three ...
According to Mochi Health, more than half of its patients lose at least 10% of their body weight within the first six months, ...
The results bring Lilly one step closer to filing for approval of the injection, retatrutide, which works differently from ...
Many telehealth companies have emerged in recent years offering easy access to GLP-1 weight loss drugs as demand has exploded ...
An expert explains how the new program, which launches July 1, will work and who is eligible ...
CicadaBio today announced that new preclinical data for CC-18, its investigational GLP-1/anti-ActRII dual-pathway fusion ...
She opened up about why she wanted to slim down.
New UC San Diego research suggests the keto diet may help reduce anorexia nervosa symptoms, with 72% of participants scoring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results